Eye Catching Stocks: LyondellBasell Industries (NYSE:LYB), Hewlett-Packard Company (NYSE:HPQ), The Hackett Group (NASDAQ:HCKT), Ruckus Wireless (NYSE:RKUS), Lifepoint Hospitals Inc. (NASDAQ:LPNT)

LyondellBasell Industries NV (NYSE:LYB) Director Milton Carroll sold 2,720 shares of the stock in a transaction that occurred on Tuesday, November 25th. The stock was sold at an average price of $90.76, for a total value of $246,867.20. LyondellBasell Industries N.V. (NYSE:LYB) belongs to Basic Materials sector. Its net profit margin is 9.80% and weekly performance is -12.78%. On last trading day company shares ended … Continue reading Eye Catching Stocks: LyondellBasell Industries (NYSE:LYB), Hewlett-Packard Company (NYSE:HPQ), The Hackett Group (NASDAQ:HCKT), Ruckus Wireless (NYSE:RKUS), Lifepoint Hospitals Inc. (NASDAQ:LPNT)

Best Stocks: AstraZeneca PLC (NYSE:AZN), Valero Energy Corporation (NYSE:VLO), Silver Standard Resources Inc. (NASDAQ:SSRI), Gravity Co., Ltd (NASDAQ:GRVY), Rogers Corporation (NYSE:ROG)

Amgen and AstraZeneca PLC (NYSE:AZN)announced that AMAGINE-2, a pivotal, multi-arm Phase 3 trial evaluating two doses of brodalumab in more than 1,800 patients with moderate-to-severe plaque psoriasis, met its primary endpoints when compared with both Stelara (ustekinumab) and placebo at week 12. AstraZeneca PLC (NYSE:AZN) belongs to Healthcare sector. Its net profit margin is 3.90% and weekly performance is -0.43%. On last trading day company … Continue reading Best Stocks: AstraZeneca PLC (NYSE:AZN), Valero Energy Corporation (NYSE:VLO), Silver Standard Resources Inc. (NASDAQ:SSRI), Gravity Co., Ltd (NASDAQ:GRVY), Rogers Corporation (NYSE:ROG)

Trending Stocks: Applied Materials, Inc. (NASDAQ:AMAT), Delta Air Lines, Inc. (NYSE:DAL), Host Hotels & Resorts, Inc. (NYSE:HST), Green Plains (NASDAQ:GPRE), Ophthotech (NASDAQ:OPHT)

Applied Materials, Inc. (NASDAQ:AMAT) declared that it will participate in Credit Suisse Technology Conference on Dec 2, 2014 at 12:00PM EST. Recently, the firm declared its fiscal Q4 2014 earnings of 27 cents per share were matched with the Zacks Consensus Estimate. The firm declared its revenues of $2.27 billion, flat sequentially but above 13.9% YoY, and within the guidance range provided by the firm. … Continue reading Trending Stocks: Applied Materials, Inc. (NASDAQ:AMAT), Delta Air Lines, Inc. (NYSE:DAL), Host Hotels & Resorts, Inc. (NYSE:HST), Green Plains (NASDAQ:GPRE), Ophthotech (NASDAQ:OPHT)

Market Movers: Halcon Resources Corp. (NYSE:HK), Itau Unibanco Holding SA (ADR) (NYSE:ITUB), Tata Motors Limited (NYSE:TTM), Pfizer Inc. (NYSE:PFE), Zafgen, Inc. (NASDAQ:ZFGN)

Halcón Resources Corporation (NYSE:HK) plans to slash spending and cut rigs next year as crude prices continue to tumble, sending some of the strongest signals so far that plummeting oil prices are taking their toll on small, independent exploration and production companies. Halcon Resources Corp. (NYSE:HK) belongs to Basic Materials sector. Its weekly performance is 10.54%. On last trading day company shares ended up $3.25. … Continue reading Market Movers: Halcon Resources Corp. (NYSE:HK), Itau Unibanco Holding SA (ADR) (NYSE:ITUB), Tata Motors Limited (NYSE:TTM), Pfizer Inc. (NYSE:PFE), Zafgen, Inc. (NASDAQ:ZFGN)

Today’s Watch List: EOG Resources, Inc. (NYSE:EOG), QUALCOMM, Inc. (NASDAQ:QCOM), Sonic Corp. (NASDAQ:SONC), Furmanite Corporation (NYSE:FRM), Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK)

EOG Resources (NYSE:EOG) was upgraded by analysts at Bernstein to an “outperform” rating in a note issued to investors on Monday. EOG Resources, Inc. (NYSE:EOG) belongs to Basic Materials sector. Its net profit margin is 15.50% and weekly performance is 4.73%. On last trading day company shares ended up $99.55. EOG Resources, Inc. (NYSE:EOG) distance from 50-day simple moving average (SMA50) is 2.11%. On Nov … Continue reading Today’s Watch List: EOG Resources, Inc. (NYSE:EOG), QUALCOMM, Inc. (NASDAQ:QCOM), Sonic Corp. (NASDAQ:SONC), Furmanite Corporation (NYSE:FRM), Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK)

Regeneron and Partner Announced Positive First Trial Results of Odyssey

Regeneron and its partner Sanofi announced positive results in the first trial of their extensive Phase III ODYSSEY program (12 trials in total) for alirocumab (REGN-727), which targets PCSK9 to lower LDL (or “bad”) cholesterol. Alirocumab showed a 47.2% reduction in LDL levels from baseline over 24 weeks in patients with primary hypercholesterolemia and moderate cardiovascular risk, compared to 15.6% in patients treated with Zetia … Continue reading Regeneron and Partner Announced Positive First Trial Results of Odyssey